发明名称 TREATMENT OF TAUOPATHIES BY PASSIVE IMMUNIZATION TARGETING THE N-TERMINAL PROJECTION DOMAIN OF TAU
摘要 A method of treating tau pathologies, such as Alzheimer's disease, involving the administration of antibodies specific to the amino terminal region of human tau (amino acid residues 6-18 or 184-195) to provide passive immunization. The administration of such antibodies can reduce total tau levels, decrease tau hyperphosphorylation, and improve reference memory. Passive immunization with antibodies targeting the N-terminal projection domain of tau reduces both total and hyperphosphorylated tau was found effective in aged 3×Tg-AD mice, a generally accepted mouse model of Alzheimer's disease and frontotemporal dementia in humans.
申请公布号 US2016102138(A1) 申请公布日期 2016.04.14
申请号 US201514880425 申请日期 2015.10.12
申请人 The Research Foundation for Mental Hygiene, Inc. 发明人 Iqbal Khalid;Grundke-Iqbal Inge
分类号 C07K16/18 主分类号 C07K16/18
代理机构 代理人
主权项 1. A pharmaceutical composition for treating a subject having a tauopathy, comprising a non-naturally occurring antibody that binds to a portion of the N-terminal projection domain of tau.
地址 Menands NY US